These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 35101249)

  • 1. Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.
    Zhang LH; Zhang WY; Xiong JM; Duan XM; Hai LN; Zhang YL; Zhang MM; Qin GF; Zhang GW
    Chin J Nat Med; 2022 Jan; 20(1):43-53. PubMed ID: 35101249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Network Pharmacology-Based Study on the Molecular Biological Mechanism of Action for Compound Kushen Injection in Anti-Cancer Effect.
    He R; Ou S; Chen S; Ding S
    Med Sci Monit; 2020 Jan; 26():e918520. PubMed ID: 31892693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compound Kushen injection inhibits EMT of gastric cancer cells via the PI3K/AKT pathway.
    Li L; Wang K; Liu Z; Lü Y; Wang C; Yi X; Guo J
    World J Surg Oncol; 2022 May; 20(1):161. PubMed ID: 35590327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An advanced network pharmacology study to explore the novel molecular mechanism of Compound Kushen Injection for treating hepatocellular carcinoma by bioinformatics and experimental verification.
    Lu S; Meng Z; Tan Y; Wu C; Huang Z; Huang J; Fu C; Stalin A; Guo S; Liu X; You L; Li X; Zhang J; Zhou W; Zhang X; Wang M; Wu J
    BMC Complement Med Ther; 2022 Mar; 22(1):54. PubMed ID: 35236335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the pharmacological effects of Compound Kushen injection on MYC-P15-CCND1 signaling pathway in nasopharyngeal carcinoma - An in vitro study.
    Wu Z; Wu C; Shi J; Huang Z; Lu S; Tan Y; You R; Hai L; Huang J; Guo S; Gao Y; Jin Z; Tao X; You L; Wu J
    J Ethnopharmacol; 2023 Oct; 315():116702. PubMed ID: 37257705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring the pharmacological mechanism of compound kushen injection in the treatment of breast cancer using
    Ye Y; Zhang B; Liang Q; Wang D; Bai F; Li Y; Wei L; Li L; Huang H; Tang Y
    Front Oncol; 2022; 12():946758. PubMed ID: 36016606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A network pharmacology approach to reveal the pharmacological targets and biological mechanism of compound kushen injection for treating pancreatic cancer based on WGCNA and in vitro experiment validation.
    Wu C; Huang ZH; Meng ZQ; Fan XT; Lu S; Tan YY; You LM; Huang JQ; Stalin A; Ye PZ; Wu ZS; Zhang JY; Liu XK; Zhou W; Zhang XM; Wu JR
    Chin Med; 2021 Nov; 16(1):121. PubMed ID: 34809653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Study on the mechanisms of compound Kushen injection for the treatment of gastric cancer based on network pharmacology.
    Zhou W; Wu J; Zhu Y; Meng Z; Liu X; Liu S; Ni M; Jia S; Zhang J; Guo S
    BMC Complement Med Ther; 2020 Jan; 20(1):6. PubMed ID: 32020871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Advanced Systems Pharmacology Strategy Reveals
    Zhou W; Wu C; Zhao C; Huang Z; Lu S; Fan X; Tan Y; Stalin A; You R; Liu X; Zhang J; Wu Z; Wu J
    Front Cell Dev Biol; 2021; 9():742421. PubMed ID: 34646828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Bioinformatics Research on Novel Mechanism of Compound Kushen Injection for Treating Breast Cancer by Network Pharmacology and Molecular Docking Verification.
    Liu S; Hu X; Fan X; Jin R; Yang W; Geng Y; Wu J
    Evid Based Complement Alternat Med; 2020; 2020():2758640. PubMed ID: 32849897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated bioinformatics analysis to decipher molecular mechanism of compound Kushen injection for esophageal cancer by combining WGCNA with network pharmacology.
    Zhou W; Wu J; Zhang J; Liu X; Guo S; Jia S; Zhang X; Zhu Y; Wang M
    Sci Rep; 2020 Jul; 10(1):12745. PubMed ID: 32728182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Uncovering the anticancer mechanism of Compound Kushen Injection against HCC by integrating quantitative analysis, network analysis and experimental validation.
    Gao L; Wang KX; Zhou YZ; Fang JS; Qin XM; Du GH
    Sci Rep; 2018 Jan; 8(1):624. PubMed ID: 29330507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Role of Emodin in the Treatment of Bladder Cancer Based on Network Pharmacology and Experimental Verification.
    Liu F; Li J; Zhou B; Shen Y; Tang J; Han J; Chen C; Shao K; Chen H; Yuan L
    Comb Chem High Throughput Screen; 2024; 27(11):1661-1675. PubMed ID: 38504574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Evidence of Compound Kushen Injection Against Lung Cancer: A Network Pharmacology-Based Investigation from Western Medicine to Traditional Medicine.
    Liang S; Li Y; Zhang X; Guo Y; Pan S
    Anticancer Agents Med Chem; 2021; 21(15):2012-2022. PubMed ID: 33573576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A metabolic data-driven systems pharmacology strategy for decoding and validating the mechanism of Compound Kushen Injection against HCC.
    Wang KX; Chen YP; Lu AP; Du GH; Qin XM; Guan DG; Gao L
    J Ethnopharmacol; 2021 Jun; 274():114043. PubMed ID: 33753143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Network-based Pharmacology and
    Long X; Chen L; Yang J; Dong T; Cheng Q; Wang W; Zou Y; Su Y; Dai W; Chen B; Zhou X
    Anticancer Agents Med Chem; 2023; 23(7):847-857. PubMed ID: 36305128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Erianin, the main active ingredient of Dendrobium chrysotoxum Lindl, inhibits precancerous lesions of gastric cancer (PLGC) through suppression of the HRAS-PI3K-AKT signaling pathway as revealed by network pharmacology and in vitro experimental verification.
    Wang Y; Chu F; Lin J; Li Y; Johnson N; Zhang J; Gai C; Su Z; Cheng H; Wang L; Ding X
    J Ethnopharmacol; 2021 Oct; 279():114399. PubMed ID: 34246740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The feasibility of using the compound kushen injection to treat cervical cancer based on network pharmacology and transcriptomics.
    Zhang Y; Xu L; Li L
    Medicine (Baltimore); 2023 Sep; 102(36):e35135. PubMed ID: 37682145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential mechanisms of osthole against bladder cancer cells based on network pharmacology, molecular docking, and experimental validation.
    Jiang Y; Zhang M; Wang L; Zhang L; Ma M; Jing M; Li J; Song R; Zhang Y; Yang Z; Zhang Y; Pu Y; Qu X; Fan J
    BMC Complement Med Ther; 2023 Apr; 23(1):122. PubMed ID: 37069622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Network pharmacology in combination with bibliometrics analysis on the mechanism of compound Kushen injection in the treatment of radiation pneumonia and lung cancer.
    Lv M; Feng Y; Zeng S; Zhang Y; Shen W; Guan W; E X; Zeng H; Zhao R; Yu J
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Dec; 397(12):9789-9809. PubMed ID: 38918234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.